CN Patent

CN105232451B — 一种含有唑来膦酸的注射用组合物

Assigned to Hangzhou Yushi Biotechnology Co ltd · Expires 2019-02-05 · 7y expired

What this patent protects

本发明专利申请提供一种处方和工艺简单，稳定性和重现性更好的含有唑来膦酸的注射用组合物。并给出制备工艺将其制备成注射液。从而达到显著增强唑来膦酸注射液存储稳定性的目的。该药物组合物的制备方法，方法简单，稳定好，易于工业化生产。

USPTO Abstract

本发明专利申请提供一种处方和工艺简单，稳定性和重现性更好的含有唑来膦酸的注射用组合物。并给出制备工艺将其制备成注射液。从而达到显著增强唑来膦酸注射液存储稳定性的目的。该药物组合物的制备方法，方法简单，稳定好，易于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105232451B
Jurisdiction
CN
Classification
—
Expires
2019-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Yushi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.